GUTS — Fractyl Health Share News
0.000.00%
Brief: Fractyl Health Reports Positive 3-Month Reveal-1 Cohort Data
Brief: Fractyl Health and Bariendo Sign Letter of Intent to Prepare for Potential Offering of Revita Across its Bariatric and Metabolic Endoscopy Centers Nationwide
Brief: Fractyl Health Announces First Quarter 2025 Financial Results And Business Updates
U.S. STOCKS ON THE MOVE-Shake Shack, SatixFy, Enova
U.S. STOCKS ON THE MOVE-Shake Shack, SatixFy, Enova
U.S. STOCKS ON THE MOVE-Fractyl Health, Keurig Dr Pepper, PVH
Fractyl Health gains on early data from weight management device trial
Brief: Fractyl Health Inc Files For Mixed Shelf Offering Of Up To $300 Million
Brief: Fractyl Health Announces Fourth Quarter and Full Year 2024 Financial Results and Business Updates
Brief: Fractyl Health Announces Positive Initial Clinical Results In First Patient Of The Reveal-1 Cohort
Brief: Fractyl Health Nomination Of RJVA-002, A GIP/GLP-1 Dual Agonist, As Its First Pancreatic Gene Therapy Candidate For Obesity
Brief: Fractyl Health To Report Third Quarter 2024 Financial Results And Provide Business Updates On Nov 12, 2024
U.S. STOCKS ON THE MOVE-Stanley Black & Decker, JetBlue Airways, Phillips 66
U.S. STOCKS ON THE MOVE-Procter & Gamble, Howmet Aerospace, Spirit Airlines
U.S. STOCKS ON THE MOVE-CrowdStrike, Merck, Pfizer
Fractyl Health up on 'breakthrough' tag for weight management device
Brief: Fractyl Health Will Accelerate Revita Weight Maintenance Clinical Study Remain-1
Brief: Fractyl Health Presents Clinical Update On Revita®
Brief: Fractyl Health Appoints Adrian Kimber As Chief Commercial Officer